U.S. markets closed
  • S&P Futures

    3,840.25
    +12.25 (+0.32%)
     
  • Dow Futures

    31,426.00
    +55.00 (+0.18%)
     
  • Nasdaq Futures

    12,844.00
    +12.25 (+0.10%)
     
  • Russell 2000 Futures

    2,192.10
    -7.90 (-0.36%)
     
  • Crude Oil

    63.24
    -0.29 (-0.46%)
     
  • Gold

    1,770.90
    -4.50 (-0.25%)
     
  • Silver

    27.44
    -0.24 (-0.88%)
     
  • EUR/USD

    1.2180
    -0.0006 (-0.05%)
     
  • 10-Yr Bond

    1.5180
    +0.1290 (+9.29%)
     
  • Vix

    28.89
    +7.55 (+35.38%)
     
  • GBP/USD

    1.4015
    +0.0002 (+0.01%)
     
  • USD/JPY

    105.9100
    -0.3200 (-0.30%)
     
  • BTC-USD

    47,023.05
    -3,730.91 (-7.35%)
     
  • CMC Crypto 200

    936.57
    -58.09 (-5.84%)
     
  • FTSE 100

    6,651.96
    -7.01 (-0.11%)
     
  • Nikkei 225

    29,421.80
    -746.47 (-2.47%)
     

Chemed's Earnings: A Preview

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Chemed (NYSE:CHE) unveils its next round of earnings this Wednesday, July 29. Get prepared with Benzinga's ultimate preview for Chemed's Q2 earnings.

Earnings and Revenue

Chemed EPS is expected to be around $3.75, according to sell-side analysts. Sales will likely be near $522.89 million. In the same quarter last year, Chemed posted EPS of $3.360 on sales of $473.58 million. The Wall Street consensus estimate for earnings would represent a 11.61% increase for the company. Revenue would be up 0.52% on a year-over-year basis. Here's how the company's EPS has stacked up against analyst estimates in the past:

EPS Estimate

3.65

4.09

3.31

3.11

EPS Actual

3.68

4.22

3.46

3.36

Revenue Estimate

520.18 M

524.19 M

478.89 M

471.72 M

Revenue Actual

515.80 M

522.32 M

480.61 M

473.58 M

Stock Performance

Shares of Chemed were trading at $469.79 as of July 28. Over the last 52-week period, shares are up 14.62%. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release.

View more earnings on CHE

Don't be surprised to see the stock move on comments made during its conference call. Chemed is scheduled to hold the call at 10:00:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/7wjfjb5w

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.